Pittenger & Anderson Inc’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-160
Closed -$3K 480
2022
Q3
$3K Hold
160
﹤0.01% 409
2022
Q2
$3K Hold
160
﹤0.01% 402
2022
Q1
$4K Hold
160
﹤0.01% 400
2021
Q4
$7K Hold
160
﹤0.01% 374
2021
Q3
$7K Hold
160
﹤0.01% 377
2021
Q2
$6K Hold
160
﹤0.01% 353
2021
Q1
$9K Sell
160
-55
-26% -$3.17K ﹤0.01% 323
2020
Q4
$11K Hold
215
﹤0.01% 312
2020
Q3
$7K Hold
215
﹤0.01% 315
2020
Q2
$6K Hold
215
﹤0.01% 315
2020
Q1
$5K Hold
215
﹤0.01% 313
2019
Q4
$6K Buy
+215
New +$5.57K ﹤0.01% 332

Other funds holding VCYT

Pittenger & Anderson Inc's VCYT Position: Q4 2022 in Review

Pittenger & Anderson Inc sold out of Veracyte (VCYT) in Q4 2022, closing a stake of 160 shares — an estimated $3K sold.

Pittenger & Anderson Inc first reported a position in VCYT in Q4 2019 and held it in 12 quarters. The position peaked at $11K in Q4 2020. 223 funds tracked by Wall St. Rank hold VCYT as of Q4 2022.

  • Pittenger & Anderson Inc reported no remaining Veracyte position as of Q4 2022 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 160 Veracyte shares in Q4 2022, an estimated $3K.
  • Pittenger & Anderson Inc first reported a position in Veracyte in Q4 2019 and held it in 12 quarters.
  • Pittenger & Anderson Inc's Veracyte position peaked at $11K in Q4 2020.
  • 223 funds tracked by Wall St. Rank held Veracyte as of Q4 2022.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2022, filed 10 Feb 2023.